Bimzelx 320 MG/2 ML autoinject 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9N38
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,685
Award facts
- Contract value 100% obligated
- $21,684.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,684.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIMZELX 320 mg/2 ml auto-injector pharmaceutical product, with an ultimate completion date of December 11, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The company, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across military and veteran healthcare systems.
AmerisourceBergen Drug Corp maintains an extensive portfolio of federal pharmaceutical and medical supply deliveries through the DLA Medical Supply Chain, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The company's federal contract performance demonstrates consistent capability to meet procurement requirements through open competition, with delivery orders ranging from modest to substantial values. The parent SPE2DX contract vehicle enables flexible global pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning AmerisourceBergen as a primary vendor in the federal medical supply ecosystem.
Quick answers
Who was awarded contract SPE2DR26F9N38?
SPE2DR26F9N38 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F9N38 worth?
The government has obligated $21,685 on SPE2DR26F9N38.
Is contract SPE2DR26F9N38 an order under another contract?
Yes. SPE2DR26F9N38 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9N38 competed?
The extent of competition for SPE2DR26F9N38 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award